stage III endometrial carcinoma
Showing 1 - 25 of >10,000
Endometrial Cancer, Stage III Endometrial Cancer, Stage III Endometrial Carcinoma Trial in United States (Intensity-modulated
Recruiting
- Endometrial Cancer
- +4 more
- Intensity-modulated radiation therapy
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Jan 10, 2023
Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in
Recruiting
- Recurrent Endometrial Carcinoma
- +12 more
- Everolimus
- +2 more
-
Houston, Texas
- +1 more
Sep 22, 2022
Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma Trial (Biopsy, Biospecimen
Not yet recruiting
- Metastatic Endometrial Carcinoma
- +7 more
- Biopsy
- +5 more
- (no location specified)
Jan 18, 2023
Ovarian Cancer, Ovarian Carcinoma, Ovarian Cancer Stage IV Trial in Boston (Exercise, Attention Control)
Recruiting
- Ovarian Cancer
- +6 more
- Exercise
- Attention Control
-
Boston, MassachusettsDana Farber Cancer Institute
May 4, 2022
Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma Trial in United States (Cisplatin,
Recruiting
- Advanced Bile Duct Carcinoma
- +33 more
- Cisplatin
- +2 more
-
Sacramento, California
- +6 more
Aug 11, 2022
Ovarian Cancer Stage III, Ovarian Cancer Stage IV, Breast Cancer Stage IV Trial in Pittsburgh (Strong Together serious game)
Completed
- Ovarian Cancer Stage III
- +12 more
- Strong Together serious game
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Dec 14, 2021
Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,
Recruiting
- Advanced Breast Carcinoma
- +73 more
- Atezolizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
May 5, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +129 more
- Cyclophosphamide
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Apr 8, 2022
Among Reproductive Age Gynecological and Breast Cancer
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +29 more
- Healthcare Activity
- Survey Administration
-
Houston, TexasM D Anderson Cancer Center
Nov 2, 2022
Ovarian Cancer, Ovarian Cancer Stage III, Ovarian Cancer Stage IV Trial in Prague (other, behavioral, dietary supplement)
Recruiting
- Ovarian Cancer
- +4 more
- Physiological intervention
- +2 more
-
Prague, CzechiaGynecologic Oncology Center in Prague
Mar 29, 2022
Advanced Endometrial Carcinoma, Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma Trial in Canada, United States
Active, not recruiting
- Advanced Endometrial Carcinoma
- +4 more
- Cabozantinib S-malate
- Nivolumab
-
Phoenix, Arizona
- +33 more
Nov 1, 2022
Stage I Endometrial Carcinoma, Stage II Endometrial Carcinoma, Stage III Endometrial Carcinoma Trial in Cleveland (lymph node
Terminated
- Stage I Endometrial Carcinoma
- +3 more
- lymph node mapping
- +5 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Aug 26, 2020
Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston
Recruiting
- Advanced Endometrial Carcinoma
- +36 more
- Glutaminase Inhibitor IPN60090
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Sep 9, 2021
Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I Trial in Beijing (statins (oral atorvastatin calcium tablet
Recruiting
- Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
- statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);
-
Beijing, Beijing, ChinaPeking University People's Hospital
Oct 22, 2023
Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I Trial in Peking (Medroxyprogesterone acetate + Atorvastatin)
Recruiting
- Atypical Endometrial Hyperplasia
- Endometrial Carcinoma Stage I
- Medroxyprogesterone acetate + Atorvastatin
-
Peking, Beijing, ChinaWang Jianliu
Dec 29, 2022
Endometrial Tumors, Endometrial Tumor Malignant, Endometrial Tumor Malignant Stage I Trial in Beijing (Indication-extended
Recruiting
- Endometrial Neoplasms
- +4 more
- Indication-extended Fertility-sparing Therapy
-
Beijing, Beijing, ChinaPeking University People's Hosoital
Jul 12, 2023
Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)
Not yet recruiting
- Papillary Renal Cell Carcinoma
- Pembrolizumab
- Placebo
- (no location specified)
Nov 24, 2023
Cancer Survivor, Endometrial Carcinoma, Stage I Uterine Corpus Cancer AJCC v7 Trial in Palo Alto, San Jose (Communication
Active, not recruiting
- Cancer Survivor
- +6 more
- Communication Intervention
- +5 more
-
Palo Alto, California
- +1 more
Oct 24, 2022
Endometrial Cancer Trial in Detroit (Quality of life questionnaire)
Recruiting
- Endometrial Cancer
- Quality of life questionnaire
-
Detroit, MichiganHenry Ford Cancer Institute
Feb 22, 2022
Advanced Endometrial Adenocarcinoma, Stage III A, B, C Trial in Greenville, Roanoke (Docetaxel and Carboplatin)
Terminated
- Advanced Endometrial Adenocarcinoma, Stage III A, B, C
- Docetaxel and Carboplatin
-
Greenville, South Carolina
- +1 more
Feb 3, 2021
Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)
Not yet recruiting
- Nasopharyngeal Carcinoma
- without concurrent cisplatin chemotherapy
- with concurrent cisplatin chemotherapy
-
Fuzhou, Fujian, ChinaDepartment of radiation oncology, Fujian cancer hospital
Oct 18, 2023
Endometrial Cancer Trial in Baltimore, Syracuse, Charlottesville (HDR vaginal brachytherapy)
Recruiting
- Endometrial Cancer
- HDR vaginal brachytherapy
-
Baltimore, Maryland
- +2 more
Jan 19, 2023